Product Information
- 4-[2-(3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione
- 4-(2-(6,7-Dimethoxy-4-Methyl-3-Oxo-3,4-Dihydroquinoxalinyl)Ethyl)-1,2,4-Triazoline-3,5-Dione
- 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione
DMEQ-TAD is a synthetic molecule that can be used in clinical studies for the treatment of acute lymphoblastic leukemia. It is a fluorimetric compound with a molecular weight of 372.5 Da, which was synthesized and characterized using synthetic methods. DMEQ-TAD has been shown to inhibit the proliferation of leukemic cells in vitro and has been shown to have anti-inflammatory properties.
Chemical properties
Technical inquiry about: 3D-FD22574 DMEQ-TAD
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.